Emmaus Medcl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EMMAUS MEDCL, and what generic and branded alternatives to EMMAUS MEDCL drugs are available?
EMMAUS MEDCL has two approved drugs.
Drugs and US Patents for Emmaus Medcl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emmaus Medcl | ENDARI | l-glutamine | FOR SOLUTION;ORAL | 208587-001 | Jul 7, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Emmaus Medcl | NUTRESTORE | l-glutamine | FOR SOLUTION;ORAL | 021667-001 | Jun 10, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Emmaus Medcl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Emmaus Medcl | NUTRESTORE | l-glutamine | FOR SOLUTION;ORAL | 021667-001 | Jun 10, 2004 | 5,288,703 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.